Literature DB >> 11231098

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder.

R F Deicken1, Y Eliaz, R Feiwell, N Schuff.   

Abstract

N-Acetylaspartate (NAA) in the anterior and mediodorsal thalamic regions was measured using proton magnetic resonance spectroscopic imaging (1H-MRSI) in 15 euthymic male patients with familial bipolar I disorder and compared to values in 15 male control subjects to determine if there was evidence for altered neuronal/axonal integrity. MRI tissue segmentation methods were also utilized to obtain tissue-contribution estimates for each MRSI voxel. Relative to the comparison group, the patients with bipolar I disorder demonstrated significantly higher NAA and creatine in both the right and left thalamus. NAA was also significantly higher in the left thalamus compared to the right in both bipolar I patients and controls. There were no group or lateralized differences in the percentages of different tissue types within the MRSI voxels, suggesting that the thalamic NAA and creatine alterations were not an artifact of variations in tissue type percentages in the MRSI voxels. There was also no significant association between NAA or creatine and illness duration. The findings of increased thalamic NAA bilaterally may represent neuronal hypertrophy or hyperplasia, reduced glial cell density, or abnormal synaptic and dendritic pruning. Increased thalamic creatine bilaterally may represent altered cellular energy metabolism and is consistent with prior studies demonstrating changes in thalamic metabolism in mood disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231098     DOI: 10.1016/s0925-4927(00)00083-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

Review 2.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

3.  Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease.

Authors:  R Grant Steen; Robert J Ogg
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  Brain γ-aminobutyric acid (GABA) detection in vivo with the J-editing (1) H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability.

Authors:  Dikoma C Shungu; Xiangling Mao; Robyn Gonzales; Tacara N Soones; Jonathan P Dyke; Jan Willem van der Veen; Lawrence S Kegeles
Journal:  NMR Biomed       Date:  2016-05-13       Impact factor: 4.044

5.  Technetium-99m ethyl cysteinate dimer (ECD) cerebral accumulation and symptom and sign severity during hypothyroidism.

Authors:  Frank V Schraml; Lori L Beason-Held
Journal:  Neuro Endocrinol Lett       Date:  2010       Impact factor: 0.765

6.  Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation.

Authors:  Jun Xu; Ulrike Dydak; Jaroslaw Harezlak; Jonathan Nixon; Mario Dzemidzic; Abigail D Gunn; Harish S Karne; Amit Anand
Journal:  Psychiatry Res       Date:  2013-06-27       Impact factor: 3.222

7.  Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chelsea T Finn; Yosef A Berlow; Megan Wardrop; Perry F Renshaw; Constance M Moore
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

Review 8.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

Review 9.  Neurochemical predictors of response to pharmacologic treatments for bipolar disorder.

Authors:  Melissa P Delbello; Stephen M Strakowski
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 8.081

10.  Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate.

Authors:  Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock; Peter H Silverstone
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.